Tag: biotechnology
-
Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy
A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy.
-
Genomics Company, Amazon Partner on Generative A.I.
A genomics company is providing precision medicine analytics from its databases with generative A.I. based on large language models from Amazon Web Services.
-
Biosensor Developed to Detect Explosives, Land Mines
Researchers from a university biochemistry lab and company developing synthetic enzymes designed techniques using engineered bacteria to detect buried land mines at longer distances.
-
Infographic – Q2 Tech Merger Values Up, Deals Down
The value of mergers and acquisitions in the global technology sector rose for the first time in over a year in the second quarter of 2023, while M&A deal counts dropped somewhat.
-
University Start-Up Developing Inhaled Gene Therapies
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases.
-
Autoimmune Neuro Disease Start-Up Raises $58M
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds.
-
Neurons from Stem Cells Produced for Overdose Therapy Tests
Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies.
-
Venture Firm, Cancer Center Start Antibody Biotech Company
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets.
-
Trial Shows Nasal Vaccine Reduces Whooping Cough Bacteria
Results of a clinical trial show a vaccine delivered as a nasal spray protects healthy people against infection from the bacteria causing whooping cough infections.
-
Trial Begins for Multi-Neurological Disease Therapy
A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders.